AzTrials
AzTrials

Infectious Disease PreventionPMT-IDNCT07790367

Protection Motivation Theory-Based Education for Infectious Disease Prevention in Primary Care

A study testing Protection Motivation Theory-Based Educational Program in people with Infectious Disease Prevention, run by Yuzuncu Yil University at 1 site in Turkey (Türkiye).

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This study aims to evaluate the effect of a Protection Motivation Theory-based educational intervention on infectious disease perception, risk awareness, and protective health behaviors among adults attending primary care services. Participants will be assigned to an intervention group or a control group. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Infectious Disease Prevention
What is being tested?
Protection Motivation Theory-Based Educational Program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
200 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Sep 2026to 1 Nov 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Being 18 years of age or older.
  • Being registered with and receiving services from the family health center where the study is conducted.
  • Being able to communicate in Turkish.
  • Voluntarily agreeing to participate in the study.
  • Being able to complete the study questionnaires and participate in the educational intervention.

Who cannot join

  • Having a condition that prevents effective communication or participation in the educational intervention.
  • Declining to participate or withdrawing consent at any stage of the study.
  • Failing to complete the required pre-intervention or post-intervention assessments.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Muhammet Faruk Yiğit, PhD contact

+90 542 424 76 29

muhammetfarukyigit@yyu.edu.tr

Turkey (Türkiye)1 site
  • Van Yuzuncu Yil University

    Van, Van, 65100

    Muhammet Faruk Yiğit, PhD, +90 542 424 76 29, muhammetfarukyigit@yyu.edu.tr

Other trials in Turkey (Türkiye)

About this study

Official title: The Effect of Protection Motivation Theory-Based Education on Infectious Disease Perception, Risk Awareness, and Protective Health Behaviors in Primary Care

This study aims to evaluate the effect of a Protection Motivation Theory-based educational intervention on infectious disease perception, risk awareness, and protective health behaviors among adults attending primary care services. Participants will be assigned to an intervention group or a control group. The intervention group will receive a face-to-face educational program based on Protection Motivation Theory, while the control group will continue to receive routine health services without an additional educational intervention during the study period. Outcomes will be assessed at baseline and at Week 4 using validated self-report measures.

Read the detailed description

This study is a controlled quasi-experimental study with a pretest-posttest design. It will be conducted among adults attending a primary care center. The study is designed to evaluate whether an educational intervention based on Protection Motivation Theory can improve participants' perceptions of infectious diseases, awareness of infectious disease risks, and protective health behaviors.

Participants will be allocated to an intervention group and a control group. Before the intervention, participants in both groups will complete baseline assessments. Participants in the intervention group will then receive a face-to-face educational program based on Protection Motivation Theory. The educational content will address routes of infectious disease transmission, prevention methods, hand hygiene, mask use, environmental hygiene, maintenance of immunity, risk awareness, and protective health behaviors. Participants in the control group will not receive the educational intervention during the study period and will continue to receive routine health services.

At Week 4, participants in both groups will complete the post-intervention assessments. Changes in infectious disease perception, risk awareness, and protective health behaviors will be evaluated by comparing pre-intervention and post-intervention measurements between and within the groups.

Being tested
Protection Motivation Theory-Based Educational Program
Keywords
Protection Motivation Theory, Infectious Diseases, Risk Awareness, Protective Health Behaviors, Health Education, Primary Health Care
Medical subject headings
Communicable Diseases, Health Education

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Protection Motivation Theory-Based Educational ProgramBehavioural

    Participants in the intervention group will receive a face-to-face educational program based on Protection Motivation Theory. The program will cover infectious disease transmission routes, prevention methods, hand hygiene, mask use, environmental hygiene, maintenance of immunity, risk awareness, and protective health behaviors. The intervention is designed to enhance threat appraisal and coping appraisal related to infectious disease prevention and to promote protective health behaviors.

Study groups in NCT07790367
Study groupRoleWhat they receive
Protection Motivation Theory-Based Education GroupExperimentalParticipants in this arm will receive a face-to-face educational program based on Protection Motivation Theory. The program will address infectious disease transmission routes, prevention methods, hand hygiene, mask use, environmental hygiene, maintenance of immunity, risk awareness, and protective health behaviors.
Receives: Behavioral: Protection Motivation Theory-Based Educational Program
Control GroupNo interventionParticipants in this arm will not receive the Protection Motivation Theory-based educational intervention during the study period and will continue to receive routine health services. They will complete the same pretest and posttest assessments as the intervention group.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Communicable Diseases Risk Awareness and Protection

    Communicable disease risk awareness and protection will be assessed using the Communicable Diseases Risk Awareness and Protection Scale (CDRAPS). The scale consists of 36 items rated on a 5-point Likert scale, with total scores ranging from 36 to 180. Higher scores indicate higher levels of communicable disease risk awareness and protection. Change in total score from baseline to Week 4 will be evaluated.

    Measured: Baseline and Week 4

  2. Change in Perception Toward Infectious Diseases

    Perception toward infectious diseases will be assessed using the Perception Scale for Infectious Diseases. The scale consists of 34 items rated on a 5-point Likert scale, with total scores ranging from 34 to 170. Higher scores indicate a more positive perception toward infectious diseases. Change in total score from baseline to Week 4 will be evaluated.

    Measured: Baseline and Week 4

  3. Change in Preventive Health Behaviors for Emerging Infectious Diseases

    Preventive health behaviors will be assessed using the Turkish version of the Emerging Infectious Diseases Preventive Health Behavior Scale (EID-PHB-T-30). The scale consists of 30 items rated on a 5-point Likert scale, with total scores ranging from 30 to 150. Higher scores indicate higher levels of preventive health behaviors against emerging infectious diseases. Change in total score from baseline to Week 4 will be evaluated.

    Measured: Baseline and Week 4

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Aug 2026
  2. Study start1 Sep 2026 (estimated)
  3. Primary completion5 Oct 2026 (estimated)
  4. Study completion1 Nov 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
Participants will be assigned to two parallel groups: an intervention group receiving a Protection Motivation Theory-based educational program and a control group receiving routine health services without the additional educational intervention during the study period. Outcomes will be assessed at baseline and at Week 4.
Masking
None (open label)
Enrolment
200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07790367
Sponsor's protocol ID
16.06.2026-251887
Acronym
PMT-ID
Status last verified
Aug 2026
First submitted
23 Aug 2026
Last updated
27 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Rakhshani T, Nikeghbal S, Kashfi SM, Kamyab A, Harsini PA, Jeihooni AK. Effect of educational intervention based on protection motivation theory on preventive behaviors of respiratory infections among hospital staff. Front Public Health. 2024 Jan 5;11:1326760. doi: 10.3389/fpubh.2023.1326760. eCollection 2023.

    PubMed 38249399

Questions about this trial

What is this clinical trial studying?

A study testing Protection Motivation Theory-Based Educational Program in people with Infectious Disease Prevention, run by Yuzuncu Yil University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 27 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Muhammet Faruk Yiğit, PhD (+90 542 424 76 29, muhammetfarukyigit@yyu.edu.tr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Communicable Diseases Risk Awareness and Protection (time frame: Baseline and Week 4). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07790367, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in